1800-272-662
Shopping Cart 0
countryflagAU
Login

Merit Medical Systems Inc

Healthcare US MMSI

69.71USD
-2.17(3.02%)

Last update at 2026-03-10T20:00:00Z

Day Range

69.5672.76
LowHigh

52 Week Range

62.5885.62
LowHigh

Fundamentals

  • Previous Close 71.88
  • Market Cap4735.61M
  • Volume850125
  • P/E Ratio47.11
  • Dividend Yield-%
  • EBITDA229.42M
  • Revenue TTM1283.31M
  • Revenue Per Share TTM22.22
  • Gross Profit TTM 519.10M
  • Diluted EPS TTM1.73

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 82.63M 53.92M -13.23100M 2.19M 49.52M
Minority interest - - - - 0.00000M
Net income 74.52M 48.45M -9.84300M 5.45M 42.02M
Selling general administrative 342.52M 335.69M 297.72M 327.27M 276.02M
Selling and marketing expenses - - - - -
Gross profit 519.10M 485.33M 401.18M 432.37M 394.77M
Reconciled depreciation 92.20M 95.78M 106.82M 104.36M 69.55M
Ebit 87.56M 60.92M -62.57500M -65.70700M -9.06400M
Ebitda 194.67M 172.44M 44.24M 38.65M 60.48M
Depreciation and amortization 107.10M 111.53M 106.82M 104.36M 69.55M
Non operating income net other 1.41M -1.73800M -1.67500M - 1.26M
Operating income 87.56M 60.92M -62.57500M -65.70700M 58.62M
Other operating expenses 1049.92M 996.36M 917.96M 955.38M 823.53M
Interest expense 6.34M 5.26M 9.99M 12.41M 10.36M
Tax provision 8.11M 5.46M -3.38800M -3.25800M 7.50M
Interest income 0.44M 0.77M 0.60M 0.29M 1.20M
Net interest income -5.90000M -4.49200M -9.39000M -12.70400M -9.16100M
Extraordinary items - - - - -3.20000M
Non recurring 8.89M 14.32M 55.44M - 1.30M
Other items - - - - 0.00000M
Income tax expense 8.11M 5.46M -3.38800M -3.25800M 7.50M
Total revenue 1150.98M 1074.75M 963.88M 994.85M 882.75M
Total operating expenses 418.04M 406.94M 355.26M 392.89M 335.55M
Cost of revenue 631.88M 589.42M 562.70M 562.49M 487.98M
Total other income expense net -4.93400M -6.99900M 49.34M 67.90M -0.54000M
Discontinued operations - - - - 0.00000M
Net income from continuing ops 74.52M 48.45M -9.84300M 5.45M 42.02M
Net income applicable to common shares 74.52M 48.45M -9.84300M 5.45M 42.02M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2325.24M 1663.97M 1648.29M 1664.40M 1757.32M
Intangible assets 325.88M 275.87M 319.27M 367.92M 445.31M
Earning assets - - - - -
Other current assets 26.20M 22.32M 16.15M 13.12M 12.50M
Total liab 1123.24M 519.57M 608.50M 705.82M 807.38M
Total stockholder equity 1202.00M 1144.40M 1039.80M 958.58M 949.94M
Deferred long term liab - 33.73M 49.61M 50.12M -
Other current liab 120.45M 129.89M 161.55M 114.76M 107.98M
Common stock 638.15M 675.17M 641.53M 606.22M 587.02M
Capital stock 638.15M 675.17M 641.53M 606.22M 587.02M
Retained earnings 575.18M 480.77M 406.26M 357.80M 368.22M
Other liab - 52.43M 76.29M 102.69M 120.73M
Good will 382.24M 359.82M 361.74M 363.53M 353.19M
Other assets - 31.93M 47.50M 227.71M 28.12M
Cash 589.14M 58.41M 67.75M 56.92M 44.32M
Cash and equivalents - - - - -
Total current liabilities 203.56M 220.65M 236.28M 185.00M 181.66M
Current deferred revenue 5.09M - - 4.60M -
Net debt 302.22M 210.34M 247.28M 378.15M 479.43M
Short term debt 12.09M 22.25M 19.11M 20.40M 19.05M
Short long term debt - 11.25M 8.44M 7.50M 7.50M
Short long term debt total 891.36M 268.75M 315.03M 435.07M 523.75M
Other stockholder equity - -11.55000M -7.99100M -5.45200M -0.29400M
Property plant equipment - 382.98M 437.57M 382.73M 459.03M
Total current assets 1108.47M 529.08M 482.21M 429.71M 454.54M
Long term investments 19.06M 15.58M 14.71M 12.04M 17.13M
Net tangible assets - 508.70M 358.79M 227.13M 151.44M
Short term investments 1.50M - - - -
Net receivables 189.26M 178.45M 172.84M 157.96M 168.53M
Long term debt 823.01M 186.76M 234.40M 343.72M 431.98M
Inventory 303.87M 265.99M 221.92M 198.02M 225.70M
Accounts payable 65.94M 68.50M 55.62M 49.84M 54.62M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -11.33400M -11.55000M -7.99100M -5.45200M -5.29400M
Additional paid in capital - - - - -
Common stock total equity - 675.17M 641.53M 606.22M 587.02M
Preferred stock total equity - - - - -
Retained earnings total equity - 480.77M 406.26M 357.80M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 32.27M 28.78M 26.71M 25.63M 24.33M
Deferred long term asset charges - - - - -
Non current assets total 1216.77M 1134.88M 1166.08M 1234.69M 1302.78M
Capital lease obligations 68.35M 70.74M 72.19M 83.84M 84.26M
Long term debt total - 186.76M 234.40M 343.72M 431.98M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -184.33300M -57.39700M -37.16100M 0.25M -134.48100M
Change to liabilities - 12.66M 6.05M 0.33M -2.29500M
Total cashflows from investing activities - -57.39700M -37.16100M -58.65200M -134.48100M
Net borrowings - -44.93800M -108.50000M -88.37500M 44.50M
Total cash from financing activities 559.27M -60.26000M -98.43500M -95.70600M 33.53M
Change to operating activities - -27.06300M -17.83800M -4.78600M -4.94500M
Net income 94.41M 74.52M 48.45M -9.84300M 5.45M
Change in cash 528.58M -7.19200M 10.83M 12.60M -23.03900M
Begin period cash flow 60.56M 67.75M 56.92M 44.32M 67.36M
End period cash flow 589.14M 60.56M 67.75M 56.92M 44.32M
Total cash from operating activities 145.15M 114.29M 147.23M 165.27M 77.81M
Issuance of capital stock 24.78M 20.07M 21.31M 6.63M 6.25M
Depreciation 101.29M 92.20M 95.78M 106.82M 104.36M
Other cashflows from investing activities - -12.36800M -2.05100M -12.91400M 0.25M
Dividends paid - 2.47M 0.58M 0.87M -
Change to inventory -32.10500M -47.92900M -25.18300M 29.43M -27.04400M
Change to account receivables -9.54500M -15.11600M -8.61800M 10.43M -17.90000M
Sale purchase of stock -5.12300M -2.47400M -0.57600M -0.86600M 6.25M
Other cashflows from financing activities 1162.58M -30.44400M -10.08900M 56.39M 229.44M
Change to netincome - 39.77M 20.83M 175.11M 22.78M
Capital expenditures 36.70M 45.03M 27.94M 49.28M 81.50M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - -3.36600M 11.63M 10.91M -
Change in working capital -70.02200M -71.39800M -17.83800M 34.24M -55.72500M
Stock based compensation 21.33M 18.04M 16.09M 14.34M 9.38M
Other non cash items 10.78M 15.86M 9.37M 31.02M 26.79M
Free cash flow 108.45M 69.26M 119.29M 115.99M -3.68400M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MMSI
Merit Medical Systems Inc		 -2.17 3.02% 69.71 47.11 21.93 3.35 3.51 3.60 19.76
ISRG
Intuitive Surgical Inc		 -7.71 1.56% 485.85 73.05 61.73 19.15 10.25 18.41 59.92
ESLOY
Essilor International SA		 -0.25 0.20% 122.50 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme		 4.90 2.00% 249.71 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company		 -1.58 0.95% 163.88 37.72 15.92 3.25 2.49 4.08 17.10

Reports Covered

Stock Research & News

View All

Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Merit Medical Systems Inc

1600 West Merit Parkway, South Jordan, UT, United States, 84095

Key Executives

Name Title Year Born
Mr. Fred P. Lampropoulos Founder, Chairman, CEO & Pres 1950
Mr. Raul Parra Jr., CPA CFO & Treasurer 1979
Mr. Brian G. Lloyd Chief Legal Officer & Corp. Sec. 1961
Mr. Joseph C. Wright Chief Commercial Officer 1970
Mr. Neil Peterson Chief Operating Officer NA
Mr. Jason Treft Chief Technology Officer NA
Mr. Joseph Pierce Chief Information Officer NA
Mr. Michel J. Voigt Chief HR Officer 1973
Mr. John Knorpp Chief Regulatory Affairs Officer NA
Dr. Nicole Priest Chief Wellness Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.